There is a general acceptance of the benefits of solid dosage forms over liquid dosage forms for stability, dosing, and administration issues1.
This booklet provides healthcare professionals with a concise summary of the drawbacks of prescribing liquid melatonin in children, with the support of clinical data.
1. European Medicines Agency, Guideline on pharmaceutical development of medicines for paediatric use, 2013. (Accessed November 2022)
A paediatric dose card illustrating the range of presentations for Slenyto®
To request this material please contact us.
Insomnia in children with ASD is perceived to be one of the most challenging health effects of autism and a successful intervention needs to define realistic and agreed outcomes that can be systematically monitored. This simple guide provides healthcare professionals with a concise summary, including a treatment algorithm, to enable treatment with Slenyto® to be optimised.
